Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hoff

Showing results (401-410 of 514) with videos related to

Pageof 52
Sort By:
Nuclear Medicine Communications|January 31, 2018
Evaluation of 18F-FDG PET-CT as a prognostic marker in advanced biliary tract cancerMaria I Braghiroli, José M Mota, Paulo S Duarte, et al.
Clinical Pharmacology and Therapeutics|December 17, 2008
A dynamic model of hand-and-foot syndrome in patients receiving capecitabineE Hénin, B You, E VanCutsem, et al.
Stem Cells and Development|November 10, 2012
Transforming pluripotency: an exon-level study of malignancy-specific transcripts in human embryonal carcinoma and embryonic stem cellsSharmini Alagaratnam, Neil Harrison, Anne Cathrine Bakken, et al.
Cancer|May 17, 2000
Combined modality treatment of locally advanced breast carcinoma in elderly patients or patients with severe comorbid conditions using tamoxifen as the primary therapyP M Hoff, V Valero, A U Buzdar, et al.
Medicine|December 30, 2018
Pembrolizumab for metastatic adrenocortical carcinoma with high mutational burden: Two case reportsJose Mauricio Mota, Luana Guimarães Sousa, Maria Ignez Braghiroli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2017
HELOISE: Phase IIIb Randomized Multicenter Study Comparing Standard-of-Care and Higher-Dose Trastuzumab Regimens Combined With Chemotherapy as First-Line Therapy in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Gastric or Gastroesophageal Junction AdenocarcinomaManish A Shah, Rui-Hua Xu, Yung-Jue Bang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 22, 2006
Chronic oxaliplatin resistance induces epithelial-to-mesenchymal transition in colorectal cancer cell linesAnthony D Yang, Fan Fan, E Ramsay Camp, et al.
Plos One|November 6, 2019
Evaluating the cross-cultural validity of the Dutch version of the Social Exclusion Index for Health Surveys (SEI-HS): A mixed methods studyAddi P L van Bergen, Annelies van Loon, Matty A S de Wit, et al.
The Lancet. Oncology|September 16, 2018
Pertuzumab plus trastuzumab and chemotherapy for HER2-positive metastatic gastric or gastro-oesophageal junction cancer (JACOB): final analysis of a double-blind, randomised, placebo-controlled phase 3 studyJosep Tabernero, Paulo M Hoff, Lin Shen, et al.
Head & Neck|August 16, 2008
Cancer of the external auditory canal and middle ear in Denmark from 1992 to 2001Anders Rørbaek Madsen, Maria G Gundgaard, Camilla M Hoff, et al.
Pageof 52

Showing results (401-410 of 514) with videos related to

Sort By:
Pageof 52
Nuclear Medicine Communications|January 31, 2018
Evaluation of 18F-FDG PET-CT as a prognostic marker in advanced biliary tract cancerMaria I Braghiroli, José M Mota, Paulo S Duarte, et al.
Clinical Pharmacology and Therapeutics|December 17, 2008
A dynamic model of hand-and-foot syndrome in patients receiving capecitabineE Hénin, B You, E VanCutsem, et al.
Stem Cells and Development|November 10, 2012
Transforming pluripotency: an exon-level study of malignancy-specific transcripts in human embryonal carcinoma and embryonic stem cellsSharmini Alagaratnam, Neil Harrison, Anne Cathrine Bakken, et al.
Cancer|May 17, 2000
Combined modality treatment of locally advanced breast carcinoma in elderly patients or patients with severe comorbid conditions using tamoxifen as the primary therapyP M Hoff, V Valero, A U Buzdar, et al.
Medicine|December 30, 2018
Pembrolizumab for metastatic adrenocortical carcinoma with high mutational burden: Two case reportsJose Mauricio Mota, Luana Guimarães Sousa, Maria Ignez Braghiroli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2017
HELOISE: Phase IIIb Randomized Multicenter Study Comparing Standard-of-Care and Higher-Dose Trastuzumab Regimens Combined With Chemotherapy as First-Line Therapy in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Gastric or Gastroesophageal Junction AdenocarcinomaManish A Shah, Rui-Hua Xu, Yung-Jue Bang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 22, 2006
Chronic oxaliplatin resistance induces epithelial-to-mesenchymal transition in colorectal cancer cell linesAnthony D Yang, Fan Fan, E Ramsay Camp, et al.
Plos One|November 6, 2019
Evaluating the cross-cultural validity of the Dutch version of the Social Exclusion Index for Health Surveys (SEI-HS): A mixed methods studyAddi P L van Bergen, Annelies van Loon, Matty A S de Wit, et al.
The Lancet. Oncology|September 16, 2018
Pertuzumab plus trastuzumab and chemotherapy for HER2-positive metastatic gastric or gastro-oesophageal junction cancer (JACOB): final analysis of a double-blind, randomised, placebo-controlled phase 3 studyJosep Tabernero, Paulo M Hoff, Lin Shen, et al.
Head & Neck|August 16, 2008
Cancer of the external auditory canal and middle ear in Denmark from 1992 to 2001Anders Rørbaek Madsen, Maria G Gundgaard, Camilla M Hoff, et al.
Pageof 52